Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ombretta Turriziani

Showing results (101-110 of 118) with videos related to

Pageof 12
Sort By:
Forensic Science, Medicine, and Pathology|December 15, 2021
Correction to: Cytokine storm and histopathological findings in 60 cases of COVID-19-related death: from viral load research to immunohistochemical quantification of major players IL-1β, IL-6, IL-15 and TNF-αPaolo Frisoni, Margherita Neri, Stefano D'Errico, et al.
Journal of Global Antimicrobial Resistance|July 23, 2017
Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary/recent or chronic HIV-infected over the period 2013-2016: Impact on susceptibility to first-line strategies including integrase strand-transfer inhibitorsSamantha Andreis, Monica Basso, Renzo Scaggiante, et al.
Forensic Science, Medicine, and Pathology|August 31, 2021
Cytokine storm and histopathological findings in 60 cases of COVID-19-related death: from viral load research to immunohistochemical quantification of major players IL-1β, IL-6, IL-15 and TNF-αPaolo Frisoni, Margherita Neri, Stefano D'Errico, et al.
The New Microbiologica|November 16, 2021
Chest computed tomography score, cycle threshold values and secondary infection in predicting COVID-19 mortalityPatrizia Pasculli, Maria A. Zingaropoli, Giorgio M. Masci, et al.
Epidemiology and Infection|February 4, 2025
SARS-CoV-2 vaccination influence in the development of long-COVID clinical phenotypesPatrizia Pasculli, Michele Antonacci, Maria Antonella Zingaropoli, et al.
Antimicrobial Agents and Chemotherapy|February 18, 2025
Efficacy, safety, and anti-inflammatory properties of the switch to a doravirine-based regimen among antiretroviral-experienced elderly people living with HIV-1: the DORAGE cohortAlessandro Lazzaro, Gregorio Egidio Recchia, Federica Alessi, et al.
Vaccine|March 18, 2024
COVID-19 vaccination in cancer patients: Immune responses one year after the third doseRoberta Campagna, Federica Dominelli, Maria Antonella Zingaropoli, et al.
Circulation Research|January 13, 2023
Toll-Like Receptor 4-Dependent Platelet-Related Thrombosis in SARS-CoV-2 InfectionRoberto Carnevale, Vittoria Cammisotto, Simona Bartimoccia, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 7, 2016
First external quality assurance program of the Italian HLA-B*57:01 Network assessing the performance of clinical virology laboratories in HLA-B*57:01 testingGenny Meini, Cinzia Dello Russo, Tiziano Allice, et al.
Scientific Reports|March 16, 2026
Dynamic changes of monocytes-related immune activation in people with HIV switching to long-acting injectable cabotegravir plus rilpivirineMaria Antonella Zingaropoli, Mariasilvia Guardiani, Anna Carraro, et al.
Pageof 12

Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
Forensic Science, Medicine, and Pathology|December 15, 2021
Correction to: Cytokine storm and histopathological findings in 60 cases of COVID-19-related death: from viral load research to immunohistochemical quantification of major players IL-1β, IL-6, IL-15 and TNF-αPaolo Frisoni, Margherita Neri, Stefano D'Errico, et al.
Journal of Global Antimicrobial Resistance|July 23, 2017
Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary/recent or chronic HIV-infected over the period 2013-2016: Impact on susceptibility to first-line strategies including integrase strand-transfer inhibitorsSamantha Andreis, Monica Basso, Renzo Scaggiante, et al.
Forensic Science, Medicine, and Pathology|August 31, 2021
Cytokine storm and histopathological findings in 60 cases of COVID-19-related death: from viral load research to immunohistochemical quantification of major players IL-1β, IL-6, IL-15 and TNF-αPaolo Frisoni, Margherita Neri, Stefano D'Errico, et al.
The New Microbiologica|November 16, 2021
Chest computed tomography score, cycle threshold values and secondary infection in predicting COVID-19 mortalityPatrizia Pasculli, Maria A. Zingaropoli, Giorgio M. Masci, et al.
Epidemiology and Infection|February 4, 2025
SARS-CoV-2 vaccination influence in the development of long-COVID clinical phenotypesPatrizia Pasculli, Michele Antonacci, Maria Antonella Zingaropoli, et al.
Antimicrobial Agents and Chemotherapy|February 18, 2025
Efficacy, safety, and anti-inflammatory properties of the switch to a doravirine-based regimen among antiretroviral-experienced elderly people living with HIV-1: the DORAGE cohortAlessandro Lazzaro, Gregorio Egidio Recchia, Federica Alessi, et al.
Vaccine|March 18, 2024
COVID-19 vaccination in cancer patients: Immune responses one year after the third doseRoberta Campagna, Federica Dominelli, Maria Antonella Zingaropoli, et al.
Circulation Research|January 13, 2023
Toll-Like Receptor 4-Dependent Platelet-Related Thrombosis in SARS-CoV-2 InfectionRoberto Carnevale, Vittoria Cammisotto, Simona Bartimoccia, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 7, 2016
First external quality assurance program of the Italian HLA-B*57:01 Network assessing the performance of clinical virology laboratories in HLA-B*57:01 testingGenny Meini, Cinzia Dello Russo, Tiziano Allice, et al.
Scientific Reports|March 16, 2026
Dynamic changes of monocytes-related immune activation in people with HIV switching to long-acting injectable cabotegravir plus rilpivirineMaria Antonella Zingaropoli, Mariasilvia Guardiani, Anna Carraro, et al.
Pageof 12